TVGN
Income statement / Annual
Last year (2023), Tevogen Bio Holdings Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Tevogen Bio Holdings Inc.'s net income was -$67,325.00.
See Tevogen Bio Holdings Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
| Research and Development
Expenses |
$0.00
|
$5.77 M
|
$2.96 M
|
| General & Administrative
Expenses |
$2.27 M
|
$953,083.00
|
$1.66 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$2.27 M
|
$953,083.00
|
$1.66 M
|
| Other Expenses |
$0.00 |
-$7.38 M |
-$10.38 M |
| Operating Expenses |
$2.27 M |
$953,083.00 |
$4.62 M |
| Cost And Expenses |
$2.27 M |
$953,083.00 |
$4.62 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$256,031.00 |
$0.00 |
$598,502.00 |
| Depreciation &
Amortization |
$197,549.00
|
$230,823.00
|
$9,377.00
|
| EBITDA |
$188,706.00
|
-$953,083.00
|
-$28,745.00
|
| EBITDA Ratio |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$58,481.98
|
$4.42 M
|
-$15.59 M
|
| Income Before Tax |
-$67,325.00 |
$4.41 M |
-$15.60 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$230,823.00 |
-$9.78 M |
| Net Income |
-$67,325.00 |
$4.41 M |
-$15.60 M |
| Net Income Ratio |
0 |
0 |
0 |
| EPS |
-0.0004 |
0.0367 |
-0.13 |
| EPS Diluted |
-0.0004 |
0.0367 |
-0.13 |
| Weighted Average Shares
Out |
$165.42 M
|
$120.00 M
|
$120.00 M
|
| Weighted Average Shares
Out Diluted |
$165.42 M
|
$120.00 M
|
$120.00 M
|
| Link |
|
|
|
